View of Recent targeted therapies addition to standard chemotherapy regimen in mismatch repair deficient (Dmmr) primary advanced or recurrent endometrial cancer, to what significance? A network meta-analysis

Return to Article Details Recent targeted therapies addition to standard chemotherapy regimen in mismatch repair deficient (Dmmr) primary advanced or recurrent endometrial cancer, to what significance? A network meta-analysis Download Download PDF

Cited by

	All	Since 2021
Citations	4811	4581
h-index	26	26
i10-index	110	110

0

2300

1150

575

1725

20152016201720182019202020212022202320242025202619 18 22 30 45 59 101 301 358 591 2201 977